<DOC>
	<DOCNO>NCT00982995</DOCNO>
	<brief_summary>The primary objective study determine complete response ( vomit need medication treat nausea ) terminally ill patient suffer nausea and/or vomiting , treat palonosetron . Another objective determine partial response ( relief nausea vomit extent patient wish continue treatment palonosetron ) treat palonosetron . Palonosetron currently approve FDA prevent nausea vomit associate chemotherapy . The investigator test medication see help relieve nausea vomit associate chemotherapy .</brief_summary>
	<brief_title>Palonosetron Treatment Nausea Vomiting Terminally Ill Patients</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<criteria>1 . Patient must least 18 year old . 2 . Patient must terminal diagnosis , estimate survival 6 month less . 3 . Patients must nausea and/or vomiting , relieve 1 antinausea medication . If patient treat antinausea medication , minimum 2 hour pass ensure medication give chance effective . If relief 2 hour , patient may treat palonosetron . 4 . Patient 's medication must review . Any medication possibly cause nausea stop possible . For example , opiate suspect cause nausea , another opiate substitute . However , effective , medication change make , patient would eligible study . 5 . Patient must able understand sign inform consent 6 . Patients bowel obstruction relieve surgery may enrol . This include patient whose obstruction technically unresectable , medically ill endure surgery , refuse surgical intervention reason 1 . Patient receive chemotherapy past 28 day . 2 . Assessment possible cause nausea vomit do record . If reversible cause nausea identify , cause treat possible . If treatment relieve nausea , patient exclude study . Possible reversible cause nausea vomit exclude : Other medical condition benign positional vertigo , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>